Clinical Trial Update: Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors [Phase 4]

View source ↗

Summary

Phase 4 trial of desogestrel and corifollitropin alfa for ovarian stimulation in donors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Corifollitropin alfa (FSH-CTP) (corifollitropin alfa)
• Desogestrel (Desogestrel)

Snippet

Sponsor: Fundacion Dexeus | Conditions: Infertility | Phase 4 | Status: WITHDRAWN